205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.49%
Negative revenue growth while LSCC stands at 0.21%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
13.22%
Gross profit growth above 1.5x LSCC's 0.96%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
597.37%
EBIT growth above 1.5x LSCC's 1.67%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
634.21%
Operating income growth above 1.5x LSCC's 1.67%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
215.38%
Net income growth above 1.5x LSCC's 1.02%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
233.33%
EPS growth of 233.33% while LSCC is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
233.33%
Diluted EPS growth of 233.33% while LSCC is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
-0.18%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.46%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
3.22%
Dividend growth of 3.22% while LSCC is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
82.20%
OCF growth at 75-90% of LSCC's 101.83%. Bill Ackman would demand better working capital management or cost discipline.
146.94%
FCF growth 50-75% of LSCC's 251.02%. Martin Whitman would see if structural disadvantages exist in generating free cash.
9.50%
10Y revenue/share CAGR under 50% of LSCC's 488.26%. Michael Burry would suspect a lasting competitive disadvantage.
-11.69%
Negative 5Y CAGR while LSCC stands at 9.79%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-40.47%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
100.19%
Below 50% of LSCC's 350.64%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
6.52%
3Y OCF/share CAGR under 50% of LSCC's 43.06%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
43.07%
10Y net income/share CAGR of 43.07% while LSCC is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
1.45%
Below 50% of LSCC's 26.33%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-45.24%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
137.33%
5Y equity/share CAGR at 50-75% of LSCC's 212.04%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
51.12%
Below 50% of LSCC's 102.36%. Michael Burry suspects a serious short-term disadvantage in building book value.
93.58%
Dividend/share CAGR of 93.58% while LSCC is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
33.51%
Dividend/share CAGR of 33.51% while LSCC is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
2.52%
3Y dividend/share CAGR of 2.52% while LSCC is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-11.07%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-19.26%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
2.61%
Asset growth 1.25-1.5x LSCC's 1.86%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
1.34%
Similar to LSCC's 1.43%. Walter Schloss finds parallel capital usage or profit distribution strategies.
-0.15%
We’re deleveraging while LSCC stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-4.90%
Our R&D shrinks while LSCC invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-31.95%
We cut SG&A while LSCC invests at 0.00%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.